Reuters logo
BRIEF-Ignyta Inc - ‍announced new preclinical data for RXDX-106​
October 2, 2017 / 9:37 PM / 2 months ago

BRIEF-Ignyta Inc - ‍announced new preclinical data for RXDX-106​

Oct 2 (Reuters) - Ignyta Inc

* Ignyta Inc - ‍announced new preclinical data for RXDX-106​

* Ignyta Inc - ‍in study, researchers demonstrated immune-mediated, single-agent anti-tumor activity of RXDX-106 in multiple tumor models​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below